Early On‐Treatment Change in SALT as a Pragmatic Predictor of Ritlecitinib Response in Moderate‐To‐Severe Alopecia Areata: A Real‐World Cohort Study

Documenti analoghi

• Safety Profile of Baricitinib in Patients With Severe Alopecia Areata: A Prospective Study
  di: Isotta Giunipero di Corteranzo, et al.
  Pubblicazione: (2025)
• The BEARD Score: A Practical Tool to Assess Beard Involvement in Alopecia Areata
  di: Giuseppe Gallo, et al.
  Pubblicazione: (2026)
• Low‐dose oral minoxidil in women affected by traction alopecia: real‐world outcomes
  di: Giuseppe Gallo, et al.
  Pubblicazione: (2024)
• Drug survival, effectiveness, and safety of brodalumab for moderate‐to‐severe psoriasis up to 3 years
  di: Luca Mastorino, et al.
  Pubblicazione: (2024)
• Trichoscopic Markers and Clinical Response Patterns With Ritlecitinib in Severe Alopecia Areata: 24‐Week Outcomes From a Prospective Real‐World Cohort
  di: Nicola Perrotta, et al.
  Pubblicazione: (2026)